Fusion Antibodies plc

Results of voting at Annual General Meeting on 27 October 2023

All resolution proposed at the AGM were passed on a poll. The results of the voting are set out below. Any votes that were for the discretion of the Chair have been included in the votes 'for'.

Percent

Resolution

Outcome

Votes cast

For

Against

Ordinary Resolutions

1.

To receive the Company's annual

Passed

11,337,478

99.84

0.16

accounts and the strategic,

directors' and auditor's reports

for the year ended 31 March

2023

2.

To reappoint Stephen Smyth, in

Passed

11,336,978

98.87

1.13

accordance with the Articles of

Association as it's the first AGM

since his appointment, as a

director

3.

To reappoint Colin Walsh, who

Passed

11,336,978

98.47

1.53

retires by rotation, as a director

4.

To reappoint

Passed

11,337,478

99.30

0.70

PricewaterhouseCoopers LLP as

auditors

5.

To authorise the Audit

Passed

11,337,478

99.24

0.76

Committee to determine the

remuneration of the auditors

6.

To authorise the directors to

Passed

11,337,478

99.17

0.83

allot relevant securities of up to

a nominal value of £792,716.19

subject to certain conditions

Special Resolutions

7.

To empower the directors to

Passed

11,337,478

98.28

1.72

allot relevant securities on a

non-pre-emptive basis subject to

certain conditions

8.

To authorise the Company to

Passed

11,337,478

98.84

1.16

make market purchases of up to

5,945,371 ordinary shares

subject to certain conditions

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Fusion Antibodies plc published this content on 27 October 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 October 2023 11:20:04 UTC.